mutations specified The reality that, as described down below, CLL therapy relies on the existence or absence of those mutations. The existing consensus is that, aside from clonal mutations, subclonal mutations that has a variant allelic frequency ranging from five to 10% (and so down below the brink of detection by common molecular techniques) may